Doing Stuff Without Evidence is the Opposite of the ‘Precautionary Principle’

The biomedical world has an irritating habit of latching onto social science terminology and tossing it around without really understanding what it means. The ‘precautionary principle’ is a good example. This phrase has been around for about 40 years in social scientific and legal studies of regulation.

The concept of the precautionary principle was first developed in relation to public policy on environmental issues but later extended into studies of occupational health and safety and the rollout of innovative technologies more generally.

In the course of the Covid pandemic, it has rolled off a large number of medical tongues but in completely the opposite direction to that established by every other field that makes use of the term.

The precautionary principle has never encouraged the introduction of innovations, programmes or interventions on the basis that they just might do some good.

It is, in fact, a conservative principle that says innovations should not be permitted unless it is established that benefits will be greater than harms. It tells the advocates for innovation that they have to look just as hard for harms as for benefits. If the harms are theoretical, then research must be done to generate evidence about them before the innovation can be considered further.

The best-known example is probably that of genetically modified food crops (GMOs). These first emerged from the lab in the mid-1990s. The basis for GMOs is brilliant science, but the developers had not done sufficient work to establish their impacts on other varieties of the same species, other species, food availability for wildlife, or human health. It was just assumed, with good reason, that genetically modified tomatoes, cotton or maize would be identical to varieties produced by conventional breeding. Many environmental and consumer groups in Europe did not agree. In the absence of evidence that these crops did not present the theoretical risks identified by their critics, they were not allowed onto the market. Their advocates could not show that the risks had been exaggerated or that any harms were outweighed by the benefits.

Read More: Doing Stuff Without Evidence is the Opposite of the ‘Precautionary Principle’

Leave a Reply

Your email address will not be published. Required fields are marked *